D2 gastrectomy: A single institution experience

14^th World Cancer & Anti-Cancer Therapy Convention

November 21-23, 2016 Dubai, UAE

Ahmed Mohamed Osama Touny

Cairo University, Egypt

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Background: Recent single institutional randomized and non randomized studies showed that D2 gastrectomy can still be performed with acceptable morbidity and mortality in experienced centers with a survival benefit. Aim of the Work: A retrospective study evaluating the long term survival data for patients subjected to D2 gastrectomy treated in the National Cancer Institute, Cairo University. Patients & Methods: 50 cases of potentially curable gastric cancer were subjected to D2 gastrectomy between. The median follow up period was 48.5 months. Patients' files were retrieved; clinicopathological and follow up data were documented. Survival analysis (disease free and overall) was done in addition to univariate and multivariate analyses of prognostic variables. Results: The operative mortality and morbidity was 4% and 12.7% respectively. The mean number of retrieved nodes was 19 (range: 9-45). Overall cumulative survival was 51% at 5 and 10 years with a plateau reached at 48 months. Multivariate analyses showed that the T stage was the single independent prognostic variable. Results compared favorably to historical data of 97 cases subjected to non D2 gastrectomy where overall and disease free survivals were around 27% with a mortality and morbidity around 14%. Conclusion: D2 gastrectomy can be performed with acceptable morbidity and mortality in specialized large centers with a survival advantage for selected cases.

Biography :

Email: ahmedtouny2003@gmail.com